Ubiquitin C-Terminal Hydrolase UCH37 (UCH37) Antibody
Pida mas información
935106861
info@markelab.com
Precio
281.25€ (80 µl)
Antibody anti-UCHL5
proveedor
Abbexareference
abx031537Tested Applications
ELISA, WB, IHCreactivity
Human, Mousestatus
RUOclonality
PolyclonalDescripción
Covalent attachment of the C-terminus of ubiquitin to cellular proteins plays a role in a variety of cellular processes. Ubiquitin C-terminal hydrolysis is catalyzed by deubiquitinating (DUB) enzymes and is necessary for several functions, including liberation of monomeric ubiquitin from the precursors encoded by ubiquitin genes and recycling of ubiquitin monomers. There are 2 distinct families of DUBs, ubiquitin-specific proteases (UBPs) and ubiquitin C-terminal hydrolases (UCHs). Mayer and Wilkinson (1989) identified 4 distinct UCH activities from bovine thymus. All 4 were thiol proteases and had high-affinity binding sites for ubiquitin. Wilkinson et al. (1989) purified the predominant isozyme, UCHL3, and raised antibodies against it. By screening a human B-cell expression library with the antibodies, the authors isolated cDNAs encoding human UCHL3. Sequence comparisons revealed that the sequence of the predicted 230-amino acid human UCHL3 protein is 54% identical to that of UCHL1.
Background
UCHL5, also known as UCH37, is a deubiquitinating enzyme (DUB) that plays a key role in the ubiquitin-proteasome system by removing ubiquitin chains from proteasomal substrates, thereby regulating protein turnover and degradation. UCHL5 interacts with the 19S regulatory particle of the 26S proteasome, facilitating the recycling of ubiquitin to maintain cellular proteostasis. It is involved in DNA repair, cell cycle progression, and stress responses, making it crucial for cellular homeostasis. UCHL5 has also been implicated in tumorigenesis, where its overexpression promotes cell survival, proliferation, and chemoresistance by preventing the degradation of oncogenic proteins. Inhibitors of UCHL5 have shown potential as anti-cancer agents by enhancing proteasomal degradation of key regulatory proteins. Knockdown studies reveal its role in impaired cell growth, defective DNA repair, and increased apoptosis, highlighting UCHL5's importance in protein homeostasis, cellular stability, and cancer progression.
Características del producto
category
Primary Antibodies
clonality
Polyclonal
reactivity
Human, Mouse
immunogen target
Ubiquitin C-Terminal Hydrolase UCH37 (UCH37)
host
Rabbit
conjugation
Unconjugated
form
Liquid
tested applications
ELISA, WB, IHC
purification
Purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
buffer
PBS containing 0.09% sodium azide.
size 1
80 µl
size 2
400 µl
storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
or code
UCHL5
dry ice
No
availability
Shipped within 5-10 working days.
alias
UCH37,CGI-70,INO80R,UCH-L5,Ubiquitin carboxyl-terminal hydrolase isozyme L5,Ubiquitin thioesterase L5
uniprot id
note
This product is for research use only.
Quizá le pueda interesar
anti- UCHL5 antibody
proveedor
FineTestreference
FNab09220Tested Applications
ELISA, IHC, WBreactivity
human,mouse,ratstatus
RUOclonality
polyclonalProtease that specifically cleaves 'Lys-48'-linked polyubiquitin chains. Deubiquitinating enzyme associated with the 19S...
Precio a consultar
Ver másRecombinant Human UCH37
proveedor
FineTestreference
P7071Tested Applications
Western Blot,ELISAstatus
RUOPrecio a consultar
Ver másUbiquitin Carboxyl Terminal Hydrolase L5 (UCHL5) Antibody
proveedor
Abbexareference
abx007186Tested Applications
WB, IHC, IF/ICCreactivity
Human, Mouse, Ratstatus
RUOclonality
PolyclonalUCHL5 Antibody is a Rabbit Polyclonal Antibody against UCHL5.
175€ (20 µl)
Ver más